| Literature DB >> 22619606 |
Jolanta Lodowska1, Daniel Wolny, Sławomir Kurkiewicz, Ludmiła Węglarz.
Abstract
Background. Bone grafts are used in the treatment of nonunion of fractures, bone tumors and in arthroplasty. Tissues preserved by lyophilization or deep freezing are used as implants nowadays. Lyophilized grafts are utilized in the therapy of birth defects and bone benign tumors, while deep-frozen ones are applied in orthopedics. The aim of the study was to compare the pyrolytic pattern, as an indirect means of the analysis of organic composition of deep-frozen and lyophilized compact part of the human bone. Methods. Samples of preserved bone tissue were subjected to thermolysis and tetrahydroammonium-hydroxide- (TMAH-) associated thermochemolysis coupled with gas chromatography and mass spectrometry (Py-GC/MS). Results. Derivatives of benzene, pyridine, pyrrole, phenol, sulfur compounds, nitriles, saturated and unsaturated aliphatic hydrocarbons, and fatty acids (C12-C20) were identified in the pyrolytic pattern. The pyrolyzates were the most abundant in derivatives of pyrrole and nitriles originated from proteins. The predominant product in pyrolytic pattern of the investigated bone was pyrrolo[1,2-α]piperazine-3,6-dione derived from collagen. The content of this compound significantly differentiated the lyophilized graft from the deep-frozen one. Oleic and palmitic acid were predominant among fatty acids of the investigated samples. The deep-frozen implants were characterized by higher percentage of long-chain fatty acids than lyophilized grafts.Entities:
Mesh:
Year: 2012 PMID: 22619606 PMCID: PMC3349107 DOI: 10.1100/2012/162406
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Chromatograms of thermolysis products of deep-frozen (a) and lyophilized (b) bone tissue.
The quantity of particular thermolysis products derived from the components of compact part of the human bone preserved by deep-freezing (F) or lyophilization (L) and used for transplantation, expressed as percentage of a given analyte in a total identified compounds.
| Symbol of compounds group | Symbol of compound | Thermolysis product | %AUP ± SD | |
|---|---|---|---|---|
| F | L | |||
| B | B1 | Benzene | 0.40 ± 0.10 | 0.33 ± 0.08 |
| B2 | Toluene | 9.33 ± 1.39 | 6.53 ± 1.70 | |
| B3 | Ethylbenzene | 0.54 ± 0.24 | 0.43 ± 0.30 | |
| B4 | Styrene | 0.73 ± 0.25 | 0.86 ± 0.33 | |
|
| ||||
| P | P1 | Pyridine | 1.33 ± 0.22 | 1.11 ± 0.19 |
| P2a | 2-Methylpyridine | 1.09 ± 0.51 | 0.95 ± 0.23 | |
| P2b | 3-Methylpyridine | |||
| P3 | 2-Ethylpyridine | 0.24 ± 0.47 | 0.11 ± 0.13 | |
| P4 | Dimethylpyridine | 0.26 ± 0.35 | 0.41 ± 0.24 | |
| P5 | Pyridinamine | 0.95 ± 0.38 | 0.85 ± 0.57 | |
|
| ||||
| Py | Py1 | Pyrrole | 7.31 ± 1.25 | 6.19 ± 1.52 |
| Py2a | 1-Methylpyrrole | |||
| Py2b | 2-Methylpyrrole | 5.52 ± 1.16 | 4.52 ± 0.69 | |
| Py2c | 3-Methylpyrrole | |||
| Py3a | 1-Ethylpyrrole | 0.48 ± 0.43 | 0.77 ± 0.42 | |
| Py3b | 2-Ethylpyrrole | |||
| Py4a | 2,3-Dimethylpyrrole | |||
| Py4b | 2,5-Dimethylpyrrole | 1.81 ± 0.96 | 1.76 ± 0.29 | |
| Py4c | 2,4-Dimethylpyrrole | |||
| Py5 | 2-Ethyl-4-methylpyrrole | 0.30 ± 0.35 | 0.38 ± 0.61 | |
| Py6 | Pyrrole-2-carbonitrile | 0.46 ± 0.92 | 1.26 ± 1.52 | |
| Py7 | Pyrrolo-[1,2- | 30.13 ± 5.57 | 20.71 ± 2.22 | |
|
| ||||
| Ph | Ph1 | Phenol | 0.57 ± 0.72 | 1.22 ± 0.72 |
| Ph2 | 4-Methylphenol | 1.46 ± 1.03 | 2.28 ± 0.73 | |
|
| ||||
| N | N1 | 2-Propenenitrile | 1.73 ± 0.14 | 1.35 ± 0.25 |
| N2 | Isobutyronitrile | 2.90 ± 1.73 | 3.64 ± 3.54 | |
| N3 | Butenenitrile | 0.12 ± 0.24 | 0.44 ± 0.25 | |
| N4 | Butanenitrile | 0.21 ± 0.25 | 0.55 ± 0.39 | |
| N5 | 4-Methyl-pentanenitrile | 1.27 ± 0.09 | 0.92 ± 0.16 | |
| N6 | Benzyl nitrile | 2.82 ± 0.56 | 2.81 ± 0.41 | |
| N7 | Benzenepropanenitrile | 0.96 ± 0.67 | 1.19 ± 0.73 | |
| N8 | Pentadecanenitrile | 0.63 ± 1.27 | 0.50 ± 1.00 | |
| N9 | Hexadecanenitrile | 1.94 ± 1.91 | 2.67 ± 1.98 | |
| N10 | Octadecenenitrile | 2.20 ± 2.57 | 4.11 ± 1.43 | |
| N11 | Octadecanenitrile | 0.92 ± 1.47 | 1.61 ± 0.32 | |
|
| ||||
| S | S1 | Methanethiol | 5.01 ± 0.85 | 3.21 ± 0.28 |
|
| ||||
| UA | UA1 | 3-Penten-1-yne | 0.00 | 0.61 ± 0.71 |
| UA2 | 1,3-Cyclohexadiene | 0.00 | 0.29 ± 0.37 | |
| UA3 | 1-Heptene | 0.00 | 0.39 ± 0.78 | |
| UA4 | 1-Octene | 0.93 ± 0.16 | 1.04 ± 0.07 | |
| UA5 | 1-Nonene | 0.53 ± 0.10 | 0.63 ± 0.04 | |
| UA6 | 1-Decene | 0.26 ± 0.52 | 0.38 ± 0.59 | |
| UA7 | 1-Undecene | 0.81 ± 0.61 | 0.78 ± 0.17 | |
| UA8 | 1-Dodecene | 0.66 ± 0.78 | 0.62 ± 0.64 | |
| UA9 | Cyclododecene | 0.00 | 1.49 ± 1.20 | |
| UA10 | 1-Tridecene | 0.49 ± 0.57 | 1.10 ± 1.12 | |
| UA11 | 1-Tetradecene | 1.77 ± 0.56 | 1.89 ± 0.30 | |
| UA12 | 1,13-Tetradecadiene | 0.17 ± 0.34 | 0.89 ± 0.90 | |
| UA13 | 1-Pentadecene | 0.00 | 0.53 ± 0.62 | |
| UA14 | 1-Heksadecene | 0.00 | 0.47 ± 0.41 | |
| UA15 | 1-Heptadecene | 0.22 ± 0.44 | 0.13 ± 0.26s | |
| UA16 | 1-Octadecene | 0.26 ± 0.51 | 1.16 ± 1.41 | |
|
| ||||
| A | A1 | Hexane | 0.00 | 0.26 ± 0.52 |
| A2 | Heptane | 0.00 | 0.20 ± 0.40 | |
| A3 | Octane | 0.66 ± 0.49 | 0.85 ± 0.14 | |
| A4 | Nonane | 0.13 ± 0.26 | 0.19 ± 0.28 | |
| A5 | Decane | 0.04 ± 0.08 | 0.42 ± 0.05 | |
| A6 | Undecane | 0.35 ± 0.41 | 0.36 ± 0.41 | |
| A7 | Dodecane | 0.00 | 0.31 ± 0.46 | |
| A8 | Tridecane | 0.29 ± 0.37 | 0.86 ± 0.55 | |
| A9 | Tetradecane | 0.00 | 0.96 ± 0.95 | |
| A10 | Pentadecane | 0.15 ± 0.30 | 0.53 ± 0.40 | |
|
| ||||
| FAE | FAE1 | Isopropyl palmitate | 2.17 ± 2.33 | 1.81 ± 2.35 |
|
| ||||
| FAA | FAA1 | Hexadecanamide | 1.52 ± 0.23 | 1.74 ± 0.64 |
| FAA2 | 9-Octadecenamide | 3.37 ± 0.81 | 3.69 ± 1.77 | |
| FAA3 | Octadecanamide | 0.21 ± 0.25 | 0.36 ± 0.10 | |
|
| ||||
| I | I1 | 2-Methylpyrazine-5-carboxylic acid | 0.00 | 0.09 ± 0.17 |
| I2 | N-Methyl-7-azabicyclo(2,2,1)hept-2-ene | 0.39 ± 0.46 | 0.24 ± 0.30 | |
| I3 | Cyclo(L-prolyl-L-prolyl) | 1.00 ± 1.25 | 0.84 ± 1.08 | |
| I4 | Squalene | 0.00 | 0.22 ± 0.26 | |
%AUP ± SD: the percent content of the chromatogram peak area of the compound with reference to the sum of the areas of the peaks of identified analytes ± standard deviation.
Figure 2Quantitative relations between the main groups of thermolysis products derived from the components of the compact part of human bone preserved by deep-freezing (F) or lyophilization (L) and classified according to their chemical structure.
Figure 3Chromatograms of fatty acid derivatives formed during the thermolysis in the presence of TMAH of deep-frozen (a) and lyophilized (b) bone.
Figure 4Comparison of the carbohydrate chain length and degree of saturation of fatty acids, the components of deep-frozen (F) and lyophilized (L) compact part of the human bone (SFA: saturated fatty acids; MUSFA: monounsaturated fatty acids; DUSFA: diunsaturated fatty acids; C12–16: fatty acids with chain length of 12 to 16 carbons; C17–20: fatty acids with chain length of 17 to 20 carbons).
The percentage of fatty acids present in deep-frozen (F) and lyophilized (L) human bone tissue.
| FAME | F | L |
|---|---|---|
| 12 : 0 | 0.34 ± 0.43 | 0.00 |
| 14 : 0 | 4.84 ± 1.41 | 4.09 ± 1.16 |
| 15 : 0 | 1.19 ± 1.00 | 1.38 ± 0.50 |
| 16 : 1 | 12.59 ± 2.80 | 8.78 ± 2.35 |
| 16 : 0 | 26.11 ± 4.73 | 25.30 ± 4.27 |
|
| 0.00 | 1.19 ± 0.57 |
| 17 : 0 | 0.00 | 0.55 ± 0.28 |
| 18 : 1 | 45.69 ± 3.32 | 42.73 ± 4.32 |
| 18 : 0 | 4.53 ± 0.55 | 7.35 ± 1.51 |
| 18 : 2 | 3.77 ± 0.58 | 6.86 ± 2.57 |
| 20 : 1 | 0.94 ± 0.19 | 1.73 ± 0.39 |
| 20 : 0 | 0.00 | 0.02 ± 0.05 |
FAME: fatty acid methyl ester.
Figure 5Dendrogram of fatty acid profiles similarity created by a numerical cluster analysis (F: deep-frozen; L: lyophilized; Tn: thin; Tc: thick).